Use App
Trending
News
Earnings
Newsletters
Work With Us
All
DIA
0.79%
SPY
1.59%
QQQ
1.28%
Trending
IBRX
22.52%
SOFI
7.13%
CAVA
7.76%
UBER
1.87%
LCID
0.65%
WDAY
8.21%
MELI
1.18%
NVTS
3.20%
ZETA
16.06%
GLW
10.91%
IBRX
22.52%
SOFI
7.13%
CAVA
7.76%
UBER
1.87%
LCID
0.65%
WDAY
8.21%
MELI
1.18%
NVTS
3.20%
ZETA
16.06%
GLW
10.91%
home
Symbol
GNOM
GNOM
Global X Funds - Global X Genomics & Biotechnology ETF
450
Volume
9,658.00
52W High
$51.42
52W Low
$27.20
50D MA
$47.23
Prev Close
$46.83
Loading...
Loading...
Feed
News
Sentiment
Fundamentals
Info
News
all
press releases
Moderna Stock Gains After FDA Accepts Company’s Revised Flu Vaccine Application For Review
The FDA has now accepted the biologics license application for review, setting a Prescription Drug User Fee Act goal date of Aug. 5, 2026.
Stocktwits
·
6d ago
Full Article
<
...
1
>
Latest GNOM News
View
Top Discussions
top
active
trending
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile